Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01339039
Title Plerixafor (AMD3100) and Bevacizumab for Recurrent High-Grade Glioma
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Patrick Y. Wen, MD
Indications

glioblastoma

malignant astrocytoma

oligodendroglioma

mixed oligodendroglioma-astrocytoma

gliosarcoma

Therapies

Bevacizumab + Plerixafor

Age Groups: adult
Covered Countries USA


No variant requirements are available.